Free Trial

Ocular Therapeutix (OCUL) Institutional Ownership

Ocular Therapeutix logo
$7.54 +0.03 (+0.40%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$7.54 0.00 (-0.07%)
As of 10/9/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Ocular Therapeutix (NASDAQ:OCUL)

Current
Institutional Ownership
Percentage
59.21%
Number of
Institutional Buyers
(last 12 months)
169
Total
Institutional Inflows
(last 12 months)
$752.10M
Number of
Institutional Sellers
(last 12 months)
47
Total
Institutional Outflows
(last 12 months)
$190.85M
Get OCUL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ocular Therapeutix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OCUL Institutional Buying and Selling by Quarter

Ocular Therapeutix Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Engineers Gate Manager LP40,800$401K0.0%N/A0.019%
9/9/2026Integrated Wealth Concepts LLC5,177$51K0.0%N/A0.002%
9/9/2026NewEdge Advisors LLC16,725$164K0.0%+21.7%0.008%
9/9/2026Squarepoint Ops LLC1,415,913$13.90M0.0%+44.4%0.645%
9/8/2026Arizona State Retirement System42,047$413K0.0%-4.2%0.019%
9/2/2026Second Line Capital LLC638,640$6.27M1.1%+20.9%0.291%
8/27/2026Corient Private Wealth LP49,629$487K0.0%+68.6%0.023%
8/26/2026Principia Wealth Advisory LLC440,618$4.33M0.9%+7.8%0.201%
8/23/2026Kraematon Investment Advisors Inc.109,967$1.08M0.8%+12.7%0.050%
8/22/2026AlphaGrep UK Ltd15,985$157K0.0%N/A0.007%
8/22/2026Raiffeisen Bank International AG100,000$990K0.0%+5.3%0.046%
8/21/2026AXQ Capital LP18,640$183K0.0%-39.2%0.008%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC287,158$2.82M0.0%-7.0%0.131%
8/19/2026Wellington Management Group LLP71,501$702K0.0%-5.1%0.033%
8/18/2026Ratan Capital Management LP70,792$695K0.2%N/A0.032%
8/17/2026Corient Private Wealth LP29,442$289K0.0%N/A0.013%
8/17/2026Bank of America Corp DE519,231$5.10M0.0%N/A0.236%
8/15/2026Man Group plc543,582$5.34M0.0%N/A0.248%
8/15/2026Jupiter Topco LLC68,500$672K0.0%N/A0.031%
8/14/2026Legal & General Group Plc117,915$1.16M0.0%N/A0.054%
8/14/2026The Manufacturers Life Insurance Company229,256$2.25M0.0%N/A0.104%
8/14/2026Algert Global LLC592,309$5.82M0.1%+9.9%0.270%
8/13/2026PEAK6 LLC26,656$262K0.0%N/A0.012%
8/12/2026Quantbot Technologies LP34,966$343K0.0%N/A0.016%
8/12/2026Ieq Capital LLC11,897$117K0.0%N/A0.005%
8/11/2026XY Capital Ltd37,400$367K0.4%N/A0.017%
8/7/2026BlackRock Inc.19,376,555$190.28M0.0%N/A8.823%
8/7/2026Deutsche Bank AG224,145$2.20M0.0%N/A0.102%
8/7/2026Trust Co. of Vermont11,450$112K0.0%N/A0.005%
8/7/2026Hikari Power Ltd17,000$167K0.0%N/A0.008%
8/6/2026Bank of New York Mellon Corp553,236$5.43M0.0%N/A0.252%
8/6/2026GSA Capital Partners LLP26,707$262K0.0%N/A0.012%
7/10/2026E. Ohman J or Asset Management AB385,000$3.78M0.1%+28.3%0.176%
7/10/2026Handelsbanken Fonder AB86,400$848K0.0%+24.7%0.039%
6/12/2026Defilade Capital Management L.P.1,487,645$12.60M1.8%+118.2%0.679%
6/4/2026Seven Fleet Capital Management LP31,296$265K0.1%+83.0%0.014%
6/3/2026NewEdge Advisors LLC13,746$116K0.0%+1,274.6%0.006%
5/19/2026NewEdge Advisors LLC13,746$116K0.0%+1,274.6%0.006%
5/19/2026Bank of America Corp DE397,092$3.36M0.0%-34.0%0.181%
5/19/2026Janus Henderson Group PLC68,500$581K0.0%-98.4%0.031%
Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.tc pixel

Uncover the real reason Trump may never end this war
5/18/2026California State Teachers Retirement System213,706$1.81M0.0%+41.8%0.098%
5/18/2026Readystate Asset Management LP883,621$7.48M0.3%N/A0.404%
5/18/2026Royal Bank of Canada26,554$225K0.0%+175.1%0.012%
5/18/2026Rock Springs Capital Management LP383,716$3.25M0.2%+11.0%0.175%
5/16/2026The Manufacturers Life Insurance Company227,808$1.93M0.0%+145.9%0.104%
5/16/2026Quantinno Capital Management LP11,612$98K0.0%N/A0.005%
5/15/2026Commodore Capital LP2,575,000$21.81M1.3%N/A1.176%
5/15/2026Octagon Capital Advisors LP3,166,600$26.82M3.0%+20.7%1.446%
5/15/2026Entropy Technologies LP15,523$131K0.0%N/A0.007%
5/14/2026Renaissance Technologies LLC1,147,982$9.72M0.0%+45.1%0.524%
5/14/2026Sei Investments Co.258,164$2.19M0.0%+52.2%0.118%
5/13/2026Cetera Investment Advisers764,615$6.48M0.0%+5.8%0.349%
5/13/2026First Trust Advisors LP308,321$2.61M0.0%+14.7%0.141%
5/12/2026XY Capital Ltd37,400$317K0.3%N/A0.017%
5/7/2026Dimensional Fund Advisors LP649,756$5.49M0.0%N/A0.297%
5/6/2026Jennison Associates LLC72,511$614K0.0%N/A0.033%
5/5/2026Bank of New York Mellon Corp475,987$4.03M0.0%-2.9%0.219%
5/4/2026Principal Financial Group Inc.13,623$115K0.0%+24.1%0.006%
5/1/2026Candriam S.C.A.949,216$8.04M0.0%+12.8%0.436%
4/27/2026Simplify Asset Management Inc.90,000$762K0.0%N/A0.041%
4/27/2026Private Advisor Group LLC15,688$133K0.0%N/A0.007%
4/27/2026Y Intercept Hong Kong Ltd54,703$463K0.0%-86.2%0.025%
4/24/2026Deltec Asset Management LLC2,340,620$19.83M3.6%-5.9%1.075%
4/24/2026Peregrine Capital Management LLC720,462$6.10M0.2%+26.2%0.331%
4/24/2026Summer Road LLC11,879,825$100.62M70.8%+6.9%5.457%
4/22/2026Pictet Asset Management Holding SA362,596$3.07M0.0%+1,229.6%0.167%
4/22/2026Union Bancaire Privee UBP SA25,000$212K0.0%+13.6%0.011%
4/21/2026Wesbanco Bank Inc.103,000$872K0.0%N/A0.047%
4/20/2026Hilton Head Capital Partners LLC4,520$38K0.0%+30.4%0.002%
4/20/2026Assenagon Asset Management S.A.45,600$386K0.0%-92.7%0.021%
4/17/2026Financial Management Network Inc.22,000$205K0.0%N/A0.010%
4/16/2026SG Americas Securities LLC26,987$229K0.0%-71.2%0.012%
4/16/2026E. Ohman J or Asset Management AB300,000$2.54M0.1%N/A0.138%
3/17/2026Rockefeller Capital Management L.P.2,572$31K0.0%N/A0.001%
3/16/2026Avoro Capital Advisors LLC10,777,777$130.84M1.3%+5.1%4.951%
3/3/2026Caitong International Asset Management Co. Ltd10,018$122K0.0%+712.5%0.005%
2/26/2026Seven Fleet Capital Management LP17,100$208K0.2%N/A0.008%
2/23/2026Virtu Financial LLC65,627$797K0.0%+470.2%0.030%
2/19/2026Invesco Ltd.895,687$10.87M0.0%-14.2%0.411%
2/18/2026XTX Topco Ltd49,073$596K0.0%+42.5%0.023%
2/18/2026Voloridge Investment Management LLC812,078$9.86M0.0%N/A0.373%
2/18/2026Wellington Management Group LLP74,317$902K0.0%+20.7%0.034%
2/18/2026SummitTX Capital L.P.94,680$1.15M0.0%N/A0.043%
2/18/2026Twinbeech Capital LP140,350$1.70M0.1%+123.3%0.064%
2/18/2026Superstring Capital Management LP418,080$5.08M2.7%N/A0.192%
2/18/2026Orbimed Advisors LLC157,300$1.91M0.0%N/A0.072%
2/18/2026Man Group plc46,089$560K0.0%N/A0.021%
2/18/2026Janus Henderson Group PLC4,229,202$51.32M0.0%+106.5%1.943%
2/18/2026Engineers Gate Manager LP154,969$1.88M0.0%+468.5%0.071%
2/18/2026Catalio Capital Management LP714,501$8.67M1.6%N/A0.328%
No. 1 stock to cash in on the death of iPhone (Ad)

Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel

Get the free ticker and see Baylin's full research now
2/18/2026Balyasny Asset Management L.P.763,559$9.27M0.0%-65.1%0.351%
2/17/2026Logos Global Management LP3,500,000$42.49M2.6%+7.7%1.608%
2/17/2026Schonfeld Strategic Advisors LLC12,364$150K0.0%N/A0.006%
2/17/2026AQR Capital Management LLC180,723$2.19M0.0%+23.9%0.083%
2/17/2026Cetera Investment Advisers722,540$8.77M0.0%+1.2%0.332%
2/17/2026Jain Global LLC25,116$305K0.0%+57.7%0.012%
2/17/2026Paradigm Biocapital Advisors LP2,935,284$35.63M0.9%-16.1%1.348%
2/17/2026Trexquant Investment LP592,877$7.20M0.1%+215.7%0.272%
2/17/2026Amundi10,589$129K0.0%N/A0.005%
2/17/2026Jump Financial LLC173,793$2.11M0.0%+179.3%0.080%


OCUL Institutional Ownership - Frequently Asked Questions

During the previous two years, 233 institutional investors and hedge funds held shares of Ocular Therapeutix. The most heavily invested institutionals were BlackRock Inc. ($190.28M), Vanguard Group Inc. ($140.52M), Deep Track Capital LP ($139.49M), Avoro Capital Advisors LLC ($130.84M), Summer Road LLC ($100.62M), TCG Crossover Management LLC ($71.51M), and Adage Capital Partners GP L.L.C. ($56.15M).Learn more on Ocular Therapeutix's institutional investors.

59.21% of Ocular Therapeutix's stock is owned by institutional investors. Learn more on OCUL's institutional investor holdings.

Of the 223 institutional investors that purchased Ocular Therapeutix's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($19.38M), Millennium Management LLC ($4.18M), Avoro Capital Advisors LLC ($3.91M), Assenagon Asset Management S.A. ($3.74M), Vanguard Group Inc. ($3.28M), Alliancebernstein L.P. ($3.26M), and Commodore Capital LP ($2.58M).

Institutional investors have bought a total of 69,528,245 shares in the last 24 months. This purchase volume represents approximately $752.10M in transactions.

Of the 47 institutional investors that sold Ocular Therapeutix's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Janus Henderson Group PLC ($4.16M), Summer Road LLC ($2.78M), Deep Track Capital LP ($2.36M), Balyasny Asset Management L.P. ($1.43M), Rosalind Advisors Inc. ($818.70K), UBS Group AG ($720.21K), and Invesco Ltd. ($643.16K).

Institutional investors have sold a total of 17,661,233 shares in the last 24 months. This volume of shares sold represents approximately $190.96M in transactions.



Institutional ownership data for NASDAQ:OCUL is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners